NAMPT and ovarian carcinoma: The expression of NAMPT is increased in urothelial carcinoma, breast cancer, stomach cancer, esophageal cancer, colorectal cancer (CRC), ovarian cancer, prostate cancer, glioblastoma, and melanoma.